Found 5 matching trials
Reduced PCV Dosing Schedules in South African Infants
PHASE3This study will evaluate the immunogenicity of a reduced dosing schedule of...
Location
Chris Hani Baragwanath Academic Hospital
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
PHASE3This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Location
GSK Investigational Site
Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants
PHASE3The primary objectives of this study are to evaluate the immunogenicity (an...
Location
Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM)
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children
N/AThis study will evaluate the persistence of immunogenicity following a redu...
Location
Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU
Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
PHASE1The purpose of this study is to assess the safety and tolerability of PATH-...
Location
Kenya Medical Research Institute/Walter Reed Project